Ecor1 Capital, Llc Portfolio Stock Holdings

According to the SEC 13F filed on August 14, 2026, Ecor1 Capital, Llc disclosed 30 stock positions valued at approximately $2.02B as of quarter-end June 30, 2026. The largest holdings include ZYMEWORKS INC, ANAPTYSBIO INC, and AKTIS ONCOLOGY INC.

Report Period
June 30, 2026
No. of Stocks
30
Portfolio Value
$2.02B
Holdings by Sector
Ecor1 Capital, Llc Portfolio Holdings in Q2 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
ZYMEWORKS INCZYMEHealthcare29.77%22,970,388--$600,445,942
ANAPTYSBIO INCANABHealthcare26.37%7,880,094--$531,906,345
AKTIS ONCOLOGY INCAKTSOther7.71%4,824,469--$155,492,636
CG ONCOLOGY INCCGONHealthcare5.26%1,494,300+392,300+35.60%$106,170,015
ETON PHARMACEUTICALS INCETONHealthcare3.90%2,171,938--$78,624,156
CRISPR THERAPEUTICS AGCRSPOther3.76%1,389,276--$75,771,113
ORIC PHARMACEUTICALS INCORICHealthcare3.61%6,728,116--$72,865,496
FIRST TRACKS BIOTHERAPEUTICSTRAXOther3.17%3,174,519+3,174,519+100.00%$63,871,322
LAKEFRONT BIOTHERAPEUTICS NVGLPGHealthcare2.48%1,667,119--$49,980,228
NEUROGENE INCNGNEHealthcare1.98%1,271,342--$39,983,706
STOKE THERAPEUTICS INCSTOKHealthcare1.19%735,000+635,000+635.00%$24,049,200
FULCRUM THERAPEUTICS INCFULCHealthcare1.19%6,549,866+6,549,866+100.00%$23,972,510
LEGEND BIOTECH CORPLEGNHealthcare1.15%800,000+800,000+100.00%$23,104,000
BRIDGEBIO ONCOLOGY THERAPEUTBBOTOther1.07%2,823,126--$21,512,220
MBX BIOSCIENCES INCMBXOther1.06%388,500-388,500-50.00%$21,445,200
ZENAS BIOPHARMA INCZBIOOther0.99%789,500--$20,037,510
ATARA BIOTHERAPEUTICS INCATRAHealthcare0.88%1,552,000+1,452,407+1458.34%$17,816,960
RELAY THERAPEUTICS INCRLAYHealthcare0.65%697,948-1,206,814-63.36%$13,058,607
AURA BIOSCIENCES INCAURAHealthcare0.59%1,666,667+1,666,667+100.00%$11,833,336
ODYSSEY THERAPEUTICS INCODTXOther0.52%555,555+555,555+100.00%$10,394,434
EIKON THERAPEUTICS INCEIKNOther0.47%732,606--$9,560,508
PHARVARIS N VPHVSOther0.40%235,000+235,000+100.00%$8,126,300
ZURA BIO LTDZURAOther0.35%1,179,715--$6,960,319
PHATHOM PHARMACEUTICALS INCPHATHealthcare0.34%625,000--$6,781,250
NURIX THERAPEUTICS INCNRIXHealthcare0.32%270,000+270,000+100.00%$6,550,200
ERASCA INCERASHealthcare0.30%330,000-570,000-63.33%$6,045,600
ELOXX PHARMACEUTICALS INCELOXOther0.28%400,000+400,000+100.00%$5,552,000
AARDVARK THERAPEUTICS INCAARDOther0.11%396,194+396,194+100.00%$2,282,077
MEREO BIOPHARMA GROUP PLCMREOHealthcare0.02%1,000,000-12,368,855-92.52%$317,700
SURROZEN INCSRZNWHealthcare0.01%4,444--$115,322
Showing 30 of 30 holdings in the latest reporting period.
Ecor1 Capital, Llc Options Holdings in Q2 2026
QuarterSymbolCompanyOptionContractsNotional Value
Q2 2026CGONCG Oncology, Inc.CALL561,500$39,894,575
Q2 2026AARDAARDVARK THERAPEUTICS INCCALL14,700$84,672
Showing 2 of 2 options positions in the latest reporting period.

Notional value represents the total exposure of the options position.

Ecor1 Capital, Llc Portfolio Stock Holdings | InsiderSet